Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Completed · Phase 2
Conditions studied: Pancreatic Cancer
In brief
This is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior treatment for metastatic disease and are eligible to receive gemcitabine and nab-paclitaxel chemotherapy as SOC.
Key facts
- Study ID
- NCT06119217
- Run by
- Trishula Therapeutics, Inc.
- People needed
- 194
- Starts
- 2024-03-25
- Expected to finish
- 2026-03-06
- Last updated by the study team
- 2026-05-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Investigative Site — Portland, Oregon, United States
- Investigative Site — Horsham, Pennsylvania, United States
- Investigative Site — Austin, Texas, United States
- Investigative Site — Dallas, Texas, United States
- Investigative Site — San Antonio, Texas, United States
- Investigative Site — Tyler, Texas, United States
- Investigative Site — Arlington, Virginia, United States
- Investigative Site — Norfolk, Virginia, United States
- Investigative Site — Roanoke, Virginia, United States
- Investigative Site — Milwaukee, Wisconsin, United States
- Investigative Site — Albury, New South Wales, Australia
- Investigative Site — Westmead, New South Wales, Australia
- Investigative Site — Herston, Queensland, Australia
- Investigative Site — Besançon, France
- Investigative Site — Dijon, France
- Investigative Site — Lille, France
- Investigative Site — Paris, France
- Investigative Site — Poitiers, France
- Investigative Site — Genova, Italy
- Investigative Site — Meldola, Italy
- Investigative Site — Milan, Italy
- Investigative Site — Pavia, Italy
- Investigative Site — Puglia, Italy
- Investigative Site — Verona, Italy
- Investigative Site — Eugene, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.